Treatment of hepatocellular carcinoma: A pivotal role for nuclear medicine?

Nuclear Medicine Communications

Volumn 22, Issue 2, 2001, Pages 119-120

  Buscombe, J R ^a   Padhy, A ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; NUCLEAR MEDICINE; PUBLICATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MICE; RADIOPHARMACEUTICALS; YTTRIUM RADIOISOTOPES;

EID: 0035103844     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200102000-00001     Document Type: Editorial

References (13)

1. 90Y microsphere into an animal model of hepatoma. Nucl Med Commun 2001; 22: 121-125.
2. Houle S, Yip TK, Shepard FA. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiol 1989; 172: 857-860.
3. Lau WY, Leung WT, Ho S. Treatment of inoperable hepatocellular carcinoma with ytrrium-90 microspheres a phase I and II study. Br J Cancer 1994; 70: 994-999.
4. Figueras J, Jaurrieta E, Valls C et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190: 580-587.
5. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18: 1094-1101.
6. Mahfouz AE, Hamm B, Mathieu D. Imaging of metastases to the liver. Eur Radiol 1996; 6: 607-614.
7. Kobayashi H, Nakajo M, Yano T, Shimabukuro K, Shinohara S. Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol). Nippon Igaku Hoshasen Gakkai Zasshi 1985; 25: 1176-1178.
8. Maini CL, Scelsa MG, Fiumara C et al. Superselective intra-arterial radiometabolic therapy with I-131 Lipiodol in hepatocellular carcinoma. Clin Nucl Med 1996; 21: 221-226.
9. Raoul JL, Bourguet P, Bretagne JF et al. Hepatic artery injection of I-131-labeled Lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 541-545.
10. Leung WT, Lau WY, Ho S et al. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 1994; 35: 1313-1318.
11. 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997; 26: 1156-1161.
12. 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Cancer 1995; 76: 2202-2210.
13. Lau WY, Leung TW, Ho SK et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999; 353: 797-801.